Not applicableAvailableNCT04710056
What this trial is testing
Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling
Who this might be right for
LipodystrophyGeneralized Lipodystrophy (GLD)Monogenic Obesity (MOB)
Regeneron Pharmaceuticals